Franco Poletti - 15 Sep 2024 Form 4 Insider Report for LivaNova PLC (LIVN)

Role: President, Cardiopulmonary
Signature: /s/ Sarah K. Mohr, Attorney-in-Fact
Issuer symbol: LIVN
Transactions as of: 15 Sep 2024
Net transactions value: $0
Form type: 4
Filing time: 17 Sep 2024, 16:05:26 UTC
Previous filing: 17 Sep 2024
Next filing: 17 Dec 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LIVN	Restricted Stock Units	Award	$0	+2,575		$0.000000	2,575	15 Sep 2024	Ordinary Shares	2,575		Direct	F1, F2
transaction	LIVN	Performance Stock Units	Award	$0	+1,287		$0.000000	1,287	15 Sep 2024	Ordinary Shares	1,287		Direct	F3, F4
transaction	LIVN	Performance Stock Units	Award	$0	+1,287		$0.000000	1,287	15 Sep 2024	Ordinary Shares	1,287		Direct	F3, F5
transaction	LIVN	Performance Stock Units	Award	$0	+2,575		$0.000000	2,575	15 Sep 2024	Ordinary Shares	2,575		Direct	F3, F6
transaction	LIVN	Stock Appreciation Rights	Award	$0	+5,885		$0.000000	5,885	15 Sep 2024	Ordinary Shares	5,885	$48.53	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of LivaNova PLC (the "Company"), GBP 1.00 par value, in accordance with the terms of the Company's 2022 Incentive Award Plan (the "Plan") and the award agreement.
F2	On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.
F3	Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement.
F4	On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow ("FCF") for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
F5	On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital ("ROIC") calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
F6	On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return ("TSR") for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
F7	On September 15, 2024, reporting person was granted stock appreciation rights ("SARs") subject to a four-year vesting in equal annual installments, the first vesting occurring on September 15, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.